These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33895125)

  • 1. Parathyroid hormone measurement in chronic kidney disease: Impact of inter-method variability on mineral bone disease assessment.
    White CA; Sarabia S; Collier CP; McCudden C; Holden RM
    Clin Biochem; 2021 Aug; 94():62-66. PubMed ID: 33895125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical Governance Issue of Parathyroid Hormone Assays and its Selection in the Management of Chronic Kidney Disease Mineral and Bone Disorders.
    Kakuta T; Ishida M; Fukagawa M
    Ther Apher Dial; 2018 Jun; 22(3):220-228. PubMed ID: 29781225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Switching between parathormone (PTH) assays: the impact on the diagnosis of renal osteodystrophy.
    Bekő G; Butz H; Berta K; Tislér A; Olajos F; Vásárhelyi B; Patócs A
    Clin Chem Lab Med; 2013 Jun; 51(6):1251-6. PubMed ID: 23241601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of iPTH values in serum and plasma samples depending on the time and temperature in patients with chronic kidney disease.
    Bencova V; Maris K; Spustova V; Gazovic V; Straussova Z; Cernohorska B; Nemethova D
    Bratisl Lek Listy; 2014; 115(7):439-41. PubMed ID: 25077368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroid Hormone Fragments: New Targets for the Diagnosis and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder.
    Chen H; Han X; Cui Y; Ye Y; Purrunsing Y; Wang N
    Biomed Res Int; 2018; 2018():9619253. PubMed ID: 30627584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hyperphosphatemia: the dangers of aiming for normal PTH levels.
    Haffner D; Leifheit-Nestler M
    Pediatr Nephrol; 2020 Mar; 35(3):485-491. PubMed ID: 31823044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Searching the optimal PTH target range in children undergoing peritoneal dialysis: new insights from international cohort studies.
    Haffner D; Schaefer F
    Pediatr Nephrol; 2013 Apr; 28(4):537-45. PubMed ID: 22893310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to Kidney Disease: Improving Global Outcomes Mineral and Bone Guidelines for Monitoring Biochemical Parameters.
    Roetker NS; Peng Y; Ashfaq A; Gilbertson DT; Wetmore JB
    Am J Nephrol; 2019; 49(3):225-232. PubMed ID: 30820015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study.
    Haarhaus M; Monier-Faugere MC; Magnusson P; Malluche HH
    Am J Kidney Dis; 2015 Jul; 66(1):99-105. PubMed ID: 25843703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
    Meng Y; Zhang H; Li Y; Li Q; Zuo L
    Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of PTH assay methodology on differential diagnosis of renal bone disease.
    Reichel H; Esser A; Roth HJ; Schmidt-Gayk H
    Nephrol Dial Transplant; 2003 Apr; 18(4):759-68. PubMed ID: 12637646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New assays for parathyroid hormone (PTH) and the relevance of PTH fragments in renal failure.
    Goodman WG
    Kidney Int Suppl; 2003 Nov; (87):S120-4. PubMed ID: 14531784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review article: Chronic kidney disease-mineral bone disorder: have we got the assays right?
    Zidehsarai MP; Moe SM
    Nephrology (Carlton); 2009 Jun; 14(4):374-82. PubMed ID: 19563378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inter-method variability in PTH measurement: implication for the care of CKD patients.
    Souberbielle JC; Boutten A; Carlier MC; Chevenne D; Coumaros G; Lawson-Body E; Massart C; Monge M; Myara J; Parent X; Plouvier E; Houillier P
    Kidney Int; 2006 Jul; 70(2):345-50. PubMed ID: 16788691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Intact PTH and Bio-Intact PTH Assays Among Non-Dialysis Dependent Chronic Kidney Disease Patients.
    Einbinder Y; Benchetrit S; Golan E; Zitman-Gal T
    Ann Lab Med; 2017 Sep; 37(5):381-387. PubMed ID: 28643486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unveiling a new era with liquid chromatography coupled with mass spectrometry to enhance parathyroid hormone measurement in patients with chronic kidney disease.
    Cavalier E; Farré-Segura J; Lukas P; Gendebien AS; Peeters S; Massonnet P; Le Goff C; Bouquegneau A; Souberbielle JC; Delatour V; Delanaye P
    Kidney Int; 2024 Feb; 105(2):338-346. PubMed ID: 37918791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The complexity of chronic kidney disease-mineral and bone disorder across stages of chronic kidney disease.
    Graciolli FG; Neves KR; Barreto F; Barreto DV; Dos Reis LM; Canziani ME; Sabbagh Y; Carvalho AB; Jorgetti V; Elias RM; Schiavi S; Moysés RMA
    Kidney Int; 2017 Jun; 91(6):1436-1446. PubMed ID: 28318623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific measurement of PTH (1-84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry.
    Lehmann G; Stein G; Hüller M; Schemer R; Ramakrishnan K; Goodman WG
    Kidney Int; 2005 Sep; 68(3):1206-14. PubMed ID: 16105052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CKD-MBD Syndrome: Hysteresis in PTH Involvement and PTH Administration for Its Management.
    Pazianas M; Miller PD
    J Bone Miner Res; 2020 Dec; 35(12):2313-2317. PubMed ID: 32780482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of hyperphosphatemia: the dangers of high PTH levels.
    Bacchetta J
    Pediatr Nephrol; 2020 Mar; 35(3):493-500. PubMed ID: 31696357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.